T-type Ca2+ channel blockers suppress the growth of human cancer cells

Jae Ho Heo1, Han Na Seo, Yun Jeong Choe

  • 1Research Institute for Basic Sciences and Department of Chemistry, College of Sciences, Kyung Hee University, 1 Hoegi-Dong, Dongdaemun-Gu, Seoul 130-701, Republic of Korea.

Insights

Potent T-type calcium channel blockers, like KYS05090, effectively inhibit human cancer cell growth. This highlights T-type calcium channels

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • T-type Ca(2+) channels are implicated in cell proliferation.
  • Understanding their precise role is crucial for cancer treatment strategies.

Purpose of the Study:

  • To investigate the role of T-type Ca(2+) channels in human cancer cell proliferation.
  • To evaluate the efficacy of novel T-type Ca(2+) channel blockers as potential anticancer agents.

Main Methods:

  • Utilized potent T-type Ca(2+) channel blockers to measure growth inhibition in human cancer cells.
  • Compared the efficacy of the most potent blocker, KYS05090, against a standard chemotherapy drug, doxorubicin.

Main Results:

  • KYS05090 demonstrated significant growth inhibition in human cancer cells, comparable to doxorubicin.
  • KYS05090 exhibited no acute toxicity, suggesting a favorable safety profile.

Conclusions:

  • T-type calcium channels play a critical role in regulating cellular phenotype transitions essential for proliferation.
  • Novel T-type Ca(2+) channel blockers, such as KYS05090, represent a promising new avenue for cancer therapy.

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...